Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts $28.81 0.00 (0.00%) (As of 02:16 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Beam Therapeutics Latest Earnings SummaryActual EPS (Nov. 5) -$1.17 Missed By -$0.01 Consensus EPS (Nov. 5) -$1.16 Beam Therapeutics announced Q3 2024 earnings on November 5, 2024, reporting an EPS of -$1.17, which missed the consensus estimate of -$1.16 by $0.01. Quarterly revenue fell 16.9% year-over-year to $14.30 million, below analysts' expectations of $14.52 million. With a trailing EPS of -$1.76, Beam Therapeutics' earnings are expected to grow next year, from ($4.66) to ($4.62) per share. Conference CallConference Call TranscriptPowered by Get Beam Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beam Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBEAM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BEAM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Beam Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$1.31-$1.18-$1.26Q2 20243-$1.24-$0.91-$1.08Q3 20244-$1.23-$0.94-$1.09Q4 20244-$1.31-$0.95-$1.14FY 202414-$5.09-$3.98-$4.57Q1 20253-$1.16-$0.90-$1.05Q2 20253-$1.19-$0.90-$1.04Q3 20253-$1.09-$0.90-$0.98Q4 20253-$1.07-$0.86-$0.96FY 202512($4.51)($3.56)($4.04) Beam Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/5/2024Q3 2024-$1.16-$1.17 -$0.01-$1.17$14.52M$14.30M8/6/2024Q2 2024-$1.13-$1.11+$0.02-$1.11$14.18M$11.80M5/7/2024Q1 2024-$1.42-$1.21+$0.21-$1.21$17.09M$7.40M2/27/2024Q4 2023-$0.69$1.73+$2.42$1.73$34.16M$316.20M11/8/2023Q3 2023-$1.33-$1.22+$0.11-$1.22$17.09M$17.20M8/8/2023Q2 2023-$1.42-$1.08+$0.34-$1.08$17.32M$20.12M Get the Latest News and Ratings for BEAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023-$1.36-$1.33+$0.03-$1.33$14.41M$24.21M2/28/2023Q4 2022-$1.34-$0.54+$0.80-$0.54$12.73M$20.04M Beam Therapeutics Earnings - Frequently Asked Questions When did Beam Therapeutics announce their last quarterly earnings? Beam Therapeutics (NASDAQ:BEAM) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on BEAM's earnings history. Did Beam Therapeutics beat their earnings estimates last quarter? In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) missed the analysts' consensus estimate of ($1.16) by $0.01 with a reported earnings per share (EPS) of ($1.17). Learn more on analysts' earnings estimate vs. BEAM's actual earnings. How can I listen to Beam Therapeutics's earnings conference call? The conference call for Beam Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Beam Therapeutics's conference call transcript? The conference call transcript for Beam Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $349.64 million. How much profit does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$1.76 earnings per share over the last four quarters. What is Beam Therapeutics's EPS forecast for next year? Beam Therapeutics's earnings are expected to grow from ($4.66) per share to ($4.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies RGEN Earnings RVMD Earnings HALO Earnings KRYS Earnings SRRK Earnings ADMA Earnings ACLX Earnings IMVT Earnings ALVO Earnings CRSP Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings Report Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW This page (NASDAQ:BEAM) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
